Pain research and patient-reported outcomes
3 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- BAYER AKTIENGESELLSCHAFT
Global pharmaceutical company contributing drug safety data, clinical expertise, and AI capabilities to Europe's largest health research consortia.
“Key participant in IMI-PainCare (acute/chronic pain, endometriosis, bladder pain syndrome) and PARADIGM (patient engagement in medicines development).”
DE59 projects - HUS-YHTYMA
Finland's largest university hospital, specializing in clinical AI, neurological disease research, and large-scale patient data validation for European health consortia.
“IMI-PainCare focuses on acute/chronic pain, deep phenotyping, biomarkers, and patient stratification for optimized pain management.”
FI18 projects - FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVA
Valencia university hospital research foundation specialising in clinical trials, personalised oncology, pain research, and AI-driven diagnostics across European consortia.
“IMI-PainCare focuses on acute/chronic pain, deep phenotyping, biomarkers, and patient stratification for optimised pain management.”
PrimaryES13 projects